NEW YORK (GenomeWeb) – Indi Molecular said today that it has entered into a co-development deal with Sigma-Aldrich to explore the use of Indi Molecular's PCC (protein catalyzed capture) agent technology in Sigma-Aldrich's line of biological reagents.

The project will analyze using the PCC agents, which are synthetic peptides capable of protein binding with similar performance to traditional antibodies and with potentially lower development times and costs, for protein research.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Researchers have sequenced the northern white rhinoceros to gauge whether it could be brought back from the edge of extinction, the New York Times reports.

Bavaria expands its forensic genetic analyses to include DNA phenotyping, raising discrimination concerns.

Tufts University researchers found a role for miRNA in transmitting stress between generations, the Economist reports.

In Science this week: gut microbiome influences liver cancer growth, spread; and more.

Jun
19
Sponsored by
Advanced Cell Diagnostics

This webinar will provide evidence for the use of RNA in situ hybridization (RNA ISH) as a replacement for immunohistochemistry (IHC) in cancer research and diagnostic applications.